Prevention of Deep Vein Thrombosis Associated with Temporary Transvenous Cardiac Pacemakers by Enoxaparin

Mohammad Javad  Zibaeenezhad; E  Atabati; K  Aghasadeghi

International Cardiovascular Research Journal

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Boards & Committees Indexing and Listing Sources Journal Metrics Publication Ethics and Publication Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Prevention of Deep Vein Thrombosis Associated with Temporary Transvenous Cardiac Pacemakers by Enoxaparin

Author(s):

Mohammad Javad Zibaeenezhad^1,*,

E Atabati¹,

K Aghasadeghi¹

1Cardiovascular Research Center, Shiraz University of Medical Scinces, Shiraz, Iran

International Cardiovascular Research Journal:Vol. 3, issue 3; e68037

Published online:Sep 30, 2009

Article type:Research Article

Received:Mar 07, 2018

Accepted:Sep 30, 2009

How to Cite:Zibaeenezhad MJ, Atabati E, Aghasadeghi K. Prevention of Deep Vein Thrombosis Associated with Temporary Transvenous Cardiac Pacemakers by Enoxaparin. Int Cardiovasc Res J. 2009;3(3):e68037. doi:

Abstract

Background: The purpose of this prospective study is to quantify the risk of lower limb deep venous thrombosis
(DVT) in patients requiring temporary transvenous femoral pacing and to evaluate the use of different enoxaparin
dosages (prophylactic or therapeutic) for thrombus prevention. Transvenous temporary cardiac pacemaker,
with catheters frequently used along the femoral vein is useful to relieve difficult bradyarrythmias and some
tachyarrythmias. Up to one-third of patients receiving transfemoral pacing develop asymptomatic DVT. At
present, there are no recommendations for thrombus prophylaxis in these patients. Besides, the efficacy in this
specific condition has not been studied.
Methods: Sixty consecutive patients who underwent transvenous femoral pacing and had no contraindication
to low molecular weight heparin (LMWH) therapy were divided into 3 groups each group consisted of 20 patients.
Group I received prophylactic enoxaparin (1mg/kg/day; subcutaneously), group II received therapeutic
enoxaparin (1 mg/kg/day every 12 hours; subcutaneously), and group III consisting of patients who were not
treated with enoxaparin was considered as control group. Patients were evaluated daily for clinical features of
DVT. Color Doppler sonography imaging was performed on both lower limbs of all patients within 24 hours
after removal of the temporary pacemakers.
Results: Of the sixty patients, two who belonged to group III, had definitive evidence of right lower limb DVT
by color Doppler sonography. These two cases of DVT were asymptomatic and had thrombosis of femoral vein.
No evidence of thrombus was detected in contra lateral lower limb. No DVT was detected among patients who
received prophylactic or therapeutic doses of enoxaparin. No heparin related complications were detected in
this study. There were no significant difference in the clinical characteristics among 2 groups (I, II) and control
group. Correlations of age and gender with occurrence of DVT were not significant (P= 0.512, 0.737).
Conclusions: This study showed that DVT is a common complication of femoral pacing, and that its incidence
can be reduced with the use of prophylaxis and therapeutic intravenous enoxaparin.

Keywords

Fulltext

The full text is available in PDF.

References

1.
The references are available in PDF.

Venous Obstruction Following Pacemaker or Implantable Cardioverter-Defibrillator Implantation, Mini Review

Mohammad Ali Akbarzadeh

Akbarzadeh MA. Venous Obstruction Following Pacemaker or Implantable Cardioverter-Defibrillator Implantation, Mini Review. Int J Cardiovasc Pract. 2016;1(2):e130038. doi: https://doi.org/10.20286/ijcp-010201

11

Apr

2022

Enoxaparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke

Khanh Nguyen Duy,

Diem Thi Nguyen,

Minh Van Le,

Long Duy Le,

Huy Cong Tran,

Nhan Huu Kha

,et al.

Duy KN, Nguyen DT, Le MV, Le LD, Tran HC, et al. Enoxaparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke. J Adv Immunopharmacol. 2022;2(1):e122415. doi: https://doi.org/10.5812/tms-122415

25

Jun

2016

Pharmacomechanical Thrombolytic Treatment in Symptomatic Acute and Subacute Deep Vein Thrombosis

Ekin Ilkeli,

Oytun Saffet Kahyaoglu,

Selim Capci,

Ramazan Buyukkaya,

Nilay Aydin Oktay,

Aysegul Koc

Ilkeli E, Saffet Kahyaoglu O, Capci S, Buyukkaya R, Aydin Oktay N, et al. Pharmacomechanical Thrombolytic Treatment in Symptomatic Acute and Subacute Deep Vein Thrombosis. I J Radiol. 2017;14(1):e13467. doi: https://doi.org/10.5812/iranjradiol.30559

30

Apr

2016

Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review

Reza Ganji,

Shahram Ala,

Mohsen Aarabi,

Babak Baghery,

Ebrahim Salehifar

Ganji R, Ala S, Aarabi M, Baghery B, Salehifar E. Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review. Iran J Pharm Res. 2016;15(2):e125175. doi: https://doi.org/10.22037/ijpr.2016.1867

31

Mar

2010

The protective effect of FXIII Val34Leu polymorphism against deep vein thrombosis: a report from Iranian Blood Transfusion Organization (IBTO)

SM Sajadi,

S Samiei,

M Kheyrandish,

MH Ahmadi,

Z Ataee

Sajadi S, Samiei S, Kheyrandish M, Ahmadi M, Ataee Z. The protective effect of FXIII Val34Leu polymorphism against deep vein thrombosis: a report from Iranian Blood Transfusion Organization (IBTO). J Inflamm Dis. 2024;13(4):e155500. doi:

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 2 weeks ago
Scopus by Title: 0
Last Update: 2 weeks ago
Scopus by Title (Ref): 0
Last Update: 2 weeks ago
CrossRef: 0
Last Update: 17 hours ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Mohammad Javad Zibaeenezhad:[PubMed][Scholar]
E Atabati:[PubMed][Scholar]
K Aghasadeghi:[PubMed][Scholar]

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Outlines

Prevention of Deep Vein Thrombosis Associated with Temporary Transvenous Cardiac Pacemakers by Enoxaparin

Abstract

Fulltext

References

Similar Articles

Venous Obstruction Following Pacemaker or Implantable Cardioverter-Defibrillator Implantation, Mini Review

Enoxaparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke

Pharmacomechanical Thrombolytic Treatment in Symptomatic Acute and Subacute Deep Vein Thrombosis

Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review

The protective effect of FXIII Val34Leu polymorphism against deep vein thrombosis: a report from Iranian Blood Transfusion Organization (IBTO)

Last Update: 2 weeks ago

Last Update: 2 weeks ago

Last Update: 2 weeks ago

Last Update: 17 hours ago